CSI Leads the Way in Ophthalmology AMD Supplies

At CSI, we understand the urgency and precision required in ophthalmology research. Among the most pressing areas is wet age-related macular degeneration (AMD) a leading cause of vision loss worldwide. Clinical studies in this field demand not only specialized medicines, but also a reliable partner who can ensure seamless supply and global reach.

With direct access to all major manufacturers, a fully scientific project team, and a proven track record across ophthalmology programs, CSI has supported numerous AMD studies from early phase through to pivotal trials.

What makes us stand out?

• Expertise: Years of experience navigating regulations in ophthalmology trials.

• Reliability: On-time supply with full compliance and chain-of-custody integrity.

• Global Reach: Delivering to sites worldwide, reducing study delays and accelerating patient access.

• Scientific expertise: Every project is managed by a team with strong scientific backgrounds, ensuring experience-based precision.

  
  

At CSI, we know that every dose matters when it comes to vision-saving treatments. Our commitment to excellence makes us the trusted choice for ophthalmology clinical supplies.

CSI leads the way in ophthalmology AMD supplies. Don't take our word or it, read our Ophthalmology Case studies:

Rapid Eylea Ophthalmology Study Supply

Long-Term, Cost-Effective Supply of Eylea EU & USA

Sourcing Lucentis for a Phase II Trial